The 6 h incubation with CML (300 μM) resulted in a significantly lower expression of TJP1 mRNA (−1.8-fold; p < 0.0332 vs. acrylamide) and of VIL1 mRNA (1.7-fold; p < 0.0284 vs. acrylamide). The gene discussed is VIL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.